Replies to post #6839 on Celsion Corporation (CLSN)

[Rawnoc]

Exactly. In fact, that's my next topic.....

TDOX appears to do the impossible -- it actually reduces the recurrence of IDR.

If so, no wonder it would be a first-line treatment used for tumors of all sizes.

It makes sense though intuitively....the so-called "distant" recurrence tumors probably are usually very close to the outside of the margins of the first tumor and we know TDOX creates a huge lesion well beyond the margin, probably killing some microsatellite cancer cells that would have gone on to become new, IDR tumoros.